Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ATNM is expected to report earnings to rise 6.76% to -39 cents per share on March 14

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q4'24

Est.

$-0.40

Q3'24

Est.

$-0.37

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.06

Q4'23

Beat

by $0.23

The last earnings report on November 14 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 234.08K shares outstanding, the current market capitalization sits at 38.06M.

View a ticker or compare two or three

Compare

ATNM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATNM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Park Avenue

Phone

+1 646 677-3870

Employees

Web

https://www.actiniumpharma.com